Aprepitant/Fosaprepitant Dimeglumine and Golimumab Subcutaneous
Determining the interaction of Aprepitant/Fosaprepitant Dimeglumine and Golimumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Generic Name: golimumab
Brand name: Simponi, Simponi SmartJect, Simponi Aria
Synonyms: Golimumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant/Fosaprepitant Dimeglumine-GoLYTELY
- Aprepitant/Fosaprepitant Dimeglumine-Gonadorelin
- Aprepitant/Fosaprepitant Dimeglumine-Gonadorelin Intravenous, Injection
- Aprepitant/Fosaprepitant Dimeglumine-Gonadotropin, Chorionic
- Aprepitant/Fosaprepitant Dimeglumine-Gonal-F
- Aprepitant/Fosaprepitant Dimeglumine-Gonal-f RFF
- Golimumab Subcutaneous-Apresazide
- Golimumab Subcutaneous-Apresoline
- Golimumab Subcutaneous-Apresoline Injection
- Golimumab Subcutaneous-Apri
- Golimumab Subcutaneous-Apriso
- Golimumab Subcutaneous-Aprizio Pak